Clinical Trial: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Sponsor and Collaborators
AIO-Studien-gGmbH, Fresenius Biotech GmbH

Principal Investigator
Florian Lordick, Prof. Dr., Medizinische Klinik III, Städtisches Klinikum Braunschweig gGmbH


Continue Reading

ClinicalTrials.gov Identifier

NCT01504256